Skip to main content

Prokupets Elena's Form 4 filing

C4 Therapeutics, Inc. (CCCC) · filed Sep 16, 2021

Accession no.
0001209191-21-056482
Filed
Sep 16, 2021
Trade date
Sep 14-16, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 7 non-derivative transactions. Open-market sales total $3.98M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Prokupets ElenaCIK 0001824823Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 14, 2021Common StockSSaleDisposed−492$50.01−$24,604.9283,522Indirect
Sep 14, 2021Common StockSSaleDisposed−492$50.03−$24,614.76587,731Indirect
Sep 15, 2021Common StockSSaleDisposed−30,000$48.71−$1,461,30053,522Indirect
Sep 15, 2021Common StockSSaleDisposed−24,193$48.97−$1,184,731.21563,538Indirect
Sep 16, 2021Common StockSSaleDisposed−346$50.01−$17,303.4653,176Indirect
Sep 16, 2021Common StockSSaleDisposed−25,807$48.62−$1,254,736.34510,731Indirect
Sep 16, 2021Common StockSSaleDisposed−346$50.01−$17,303.46510,385Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)